Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®)-Reference-Cited by-同舟云学术

Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®)

Published:2011-10-22 Issue:2 Volume:269 Page:361-362
ISSN:0937-4477
Container-title:European Archives of Oto-Rhino-Laryngology
language:en
Short-container-title:Eur Arch Otorhinolaryngol

Author:

Tjon Pian Gi Robin E. A.,Dietz Andreas,Djukic Vojko,Eckel Hans E.,Friedrich Gerhard,Golusinski Wojciech,Hantzakos Anastasios,Lawson George,Remacle Marc,Rihkanen Heikki,Dikkers Frederik G.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Otorhinolaryngology

Link

http://www.springerlink.com/index/pdf/10.1007/s00405-011-1804-7

Reference10 articles.

1. Snoeck R, Andrei G, De Clercq E (1998) Specific therapies for human papilloma virus infections. Curr Opin Infect Dis 11:733–737

2. Cundy KC (1999) Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet 36:127–143

3. Naiman AN, Ceruse P, Coulombeau B, Froehlich P (2003) Intralesional cidofovir and surgical excision for laryngeal papillomatosis. Laryngoscope 113:2174–2181

4. Pransky SM, Albright JT, Magit AE (2003) Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir. Laryngoscope 113:1583–1587

5. Dikkers FG (2006) Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir: a prospective study. Eur Arch Otorhinolaryngol 263:440–443

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumori benigni della laringe;EMC - Otorinolaringoiatria;2024-03

2. Tumores benignos de la laringe;EMC - Otorrinolaringología;2024-02

3. La papillomatosi laringea ricorrente: strategie terapeutiche multimodali. Revisione della letteratura e analisi retrospettiva multicentrica;Acta Otorhinolaryngologica Italica;2023-04

4. Recurrent Respiratory Papillomatosis;Airway diseases;2023

5. Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects;Frontiers in Chemistry;2022-05-20